Literature DB >> 16293620

Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.

Roman A Melnyk1, Krissi M Hewitt, D Borden Lacy, Henry C Lin, Chris R Gessner, Sheng Li, Virgil L Woods, R John Collier.   

Abstract

Anthrax lethal toxin assembles at the surface of mammalian cells when the lethal factor (LF) binds via its amino-terminal domain, LF(N), to oligomeric forms of activated protective antigen (PA). LF x PA complexes are then trafficked to acidified endosomes, where PA forms heptameric pores in the bounding membrane and LF translocates through these pores to the cytosol. We used enhanced peptide amide hydrogen/deuterium exchange mass spectrometry and directed mutagenesis to define the surface on LF(N) that interacts with PA. A continuous surface encompassing one face of LF(N) became protected from deuterium exchange when LF(N) was bound to a PA dimer. Directed mutational analysis demonstrated that residues within this surface on LF(N) interact with Lys-197 on two PA subunits simultaneously, thereby showing that LF(N) spans the PA subunit:subunit interface and explaining why heptameric PA binds a maximum of three LF(N) molecules. Our results elucidate the structural basis for anthrax lethal toxin assembly and may be useful in developing drugs to block toxin action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293620     DOI: 10.1074/jbc.M511164200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Ratcheting up protein translocation with anthrax toxin.

Authors:  Geoffrey K Feld; Michael J Brown; Bryan A Krantz
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

2.  Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.

Authors:  Geoffrey K Feld; Katie L Thoren; Alexander F Kintzer; Harry J Sterling; Iok I Tang; Shoshana G Greenberg; Evan R Williams; Bryan A Krantz
Journal:  Nat Struct Mol Biol       Date:  2010-10-31       Impact factor: 15.369

3.  Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.

Authors:  Stephen J Juris; Roman A Melnyk; Robert E Bolcome; Joanne Chan; R John Collier
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

4.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

5.  A conserved MutS homolog connector domain interface interacts with MutL homologs.

Authors:  Marc L Mendillo; Victoria V Hargreaves; Jonathan W Jamison; Ashley O Mo; Sheng Li; Christopher D Putnam; Virgil L Woods; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 6.  Membrane translocation by anthrax toxin.

Authors:  R John Collier
Journal:  Mol Aspects Med       Date:  2009-06-27

7.  Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.

Authors:  Laura D Jennings-Antipov; Likai Song; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

8.  Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.

Authors:  Maheshinie Rajapaksha; Jack F Eichler; Jan Hajduch; David E Anderson; Kenneth L Kirk; James G Bann
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.

Authors:  Shilpi Sharma; Diane Thomas; John Marlett; Marianne Manchester; John A T Young
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

10.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.